Incidence and Predictors of Loss to Follow-Up Among Adults on Antiretroviral Therapy in South Gondar Governmental Hospitals, Ethiopia: Retrospective Cohort Study

References

• Hønge BL, Jespersen S, Nordentoft PB, et al. Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study. BMJ Open. 2013;3(10):e003499. doi:10.1136/bmjopen-2013-003499
   PubMed Web of Science ®Google Scholar
• Alene KA, Elagali A, Barth DD, et al. Spatial codistribution of HIV, tuberculosis and malaria in Ethiopia. BMJ Global Health. 2022;7(2):e007599. doi:10.1136/bmjgh-2021-007599
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV; 2015.
   Google Scholar
• Ending A. Progress towards the 90–90–90 targets–global AIDS update. Geneva: Joint United Nations Programme on HIV. AIDS; 2017.
   Google Scholar
• Mberi MN, Kuonza LR, Dube NM, et al. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004–2012: a cohort study. BMC Health Serv Res. 2015;15(1):1–11. doi:10.1186/s12913-015-0912-2
   PubMedGoogle Scholar
• Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830–839. doi:10.1056/NEJMoa1600693
   PubMed Web of Science ®Google Scholar
• Ahmed I, Gugsa ST, Lemma S, et al. Predictors of loss to follow-up before HIV treatment initiation in Northwest Ethiopia: a case control study. BMC Public Health. 2013;13(1):1–9. doi:10.1186/1471-2458-13-867
   PubMedGoogle Scholar
• Yao H, Chen J-H, Xu Y-F. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry. 2020;7(4):e21. doi:10.1016/S2215-0366(20)30090-0
   PubMed Web of Science ®Google Scholar
• Assefa Y, Jerene D, Lulseged S, et al. Rapid scale-up of antiretroviral treatment in Ethiopia: successes and system-wide effects. PLoS Med. 2009;6(4):e1000056. doi:10.1371/journal.pmed.1000056
   PubMed Web of Science ®Google Scholar
• Assefa Y, Kiflie A, Tesfaye D, et al. Outcomes of antiretroviral treatment program in Ethiopia: retention of patients in care is a major challenge and varies across health facilities. BMC Health Serv Res. 2011;11:1–7. doi:10.1186/1472-6963-11-81
   PubMed Web of Science ®Google Scholar
• Wubshet M, Berhane Y, Worku A, et al. High loss to followup and early mortality create substantial reduction in patient retention at antiretroviral treatment program in north-west Ethiopia. Int Scholar Res Notices. 2012;2012:9.
   Google Scholar
• Gerver SM, Chadborn TR, Ibrahim F, et al. High rate of loss to clinical follow up among African HIV-infected patients attending a London clinic: a retrospective analysis of a clinical cohort. J Int AIDS Soc. 2010;13(1):1–10. doi:10.1186/1758-2652-13-29
   PubMedGoogle Scholar
• Opio D, Semitala FC, Kakeeto A, et al. Loss to follow-up and associated factors among adult people living with HIV at public health facilities in Wakiso district, Uganda: a retrospective cohort study. BMC Health Serv Res. 2019;19(1):1–10. doi:10.1186/s12913-019-4474-6
   PubMed Web of Science ®Google Scholar
• Kweyamba M, Buregyeya E, Kusiima J, et al. Loss to follow-up among HIV positive pregnant and lactating mothers on lifelong antiretroviral therapy for PMTCT in rural Uganda. Adv Public Health. 2018;2018:1–9. doi:10.1155/2018/7540587
   Google Scholar
• Mekonnen N, Abdulkadir M, Shumetie E, et al. Incidence and predictors of loss to follow-up among HIV infected adults after initiation of first line anti-retroviral therapy at University of Gondar comprehensive specialized Hospital Northwest Ethiopia, 2018: retrospective follow up study. BMC Res Notes. 2019;12(1):1–7. doi:10.1186/s13104-019-4154-y
   PubMed Web of Science ®Google Scholar
• Tadesse K, Fisiha H. Predictors of loss to follow up of patients enrolled on antiretroviral therapy: a retrospective cohort study. J AIDS Clin Res. 2014;5(393):2.
   Google Scholar
• Birhanu MY, Leshargie CT, Alebel A, et al. Incidence and predictors of loss to follow-up among HIV-positive adults in northwest Ethiopia: a retrospective cohort study. Trop Med Health. 2020;48(1):78. doi:10.1186/s41182-020-00266-z
   PubMed Web of Science ®Google Scholar
• Seifu W, Ali W, Meresa B. Predictors of loss to follow up among adult clients attending antiretroviral treatment at Karamara general hospital, Jigjiga town, Eastern Ethiopia, 2015: a retrospective cohort study. BMC Infect Dis. 2018;18(1):1–8. doi:10.1186/s12879-018-3188-4
   PubMed Web of Science ®Google Scholar
• Megerso A, Garoma S, Eticha T, et al. Predictors of loss to follow-up in antiretroviral treatment for adult patients in the Oromia region, Ethiopia. HIV/AIDS Res Palliat Care;2016. 83–92. doi:10.2147/HIV.S98137
   Google Scholar
• World Health Organization. Retention in HIV programmes: defining the challenges and identifying solutions: meeting report, 13–15 September 2011; 2012.
   Google Scholar
• Shiferaw WS, Belete AM, Adela A, et al. Incidence and predictors of loss to follow-up among adult HIV-infected patients taking antiretroviral therapy at North Shewa zone public Hospitals, Northeast Ethiopia: a retrospective follow-up study. Afr Health Sci. 2022;22(2):12–26. doi:10.4314/ahs.v22i2.3
   PubMed Web of Science ®Google Scholar
• Teshale AB, Tsegaye AT, Wolde HF, Price MA. Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: a competing risk regression modeling. PLoS One. 2020;15(1):e0227473. doi:10.1371/journal.pone.0227473
   PubMed Web of Science ®Google Scholar
• Dejen D, Jara D, Yeshanew F, et al. Attrition and its predictors among adults receiving first-line antiretroviral therapy in Woldia town public health facilities, Northeast Ethiopia: a retrospective cohort study. HIV/AIDS Res Palliat Care;2021. 445–454. doi:10.2147/HIV.S304657
   Google Scholar
• Bekolo CE, Webster J, Batenganya M, et al. Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon. BMC Res Notes. 2013;6(1):1–16. doi:10.1186/1756-0500-6-512
   PubMedGoogle Scholar
• Gebremichael MA, Gurara MK, Weldehawaryat HN, et al. Predictors of loss to follow-up among HIV-infected adults after initiation of the first-line antiretroviral therapy at Arba Minch General Hospital, Southern Ethiopia: a 5-year retrospective cohort study. Biomed Res Int. 2021;2021:1–12. doi:10.1155/2021/8659372
   PubMed Web of Science ®Google Scholar
• Birhanu MY, Leshargie CT, Alebel A, et al. Incidence and predictors of loss to follow-up among HIV-positive adults in northwest Ethiopia: a retrospective cohort study. Trop Med Health. 2020;48(1):1–10.
   PubMed Web of Science ®Google Scholar
• Dessu S, Mesele M, Habte A, et al. Time until loss to follow-up, incidence, and predictors among adults taking ART at public hospitals in Southern Ethiopia. HIV/AIDS Res Palliat Care. 2021;Volume 13:205–215. doi:10.2147/HIV.S296226
   Google Scholar
• Assemie MA, Muchie KF, Ayele TA. Incidence and predictors of loss to follow up among HIV-infected adults at Pawi General Hospital, northwest Ethiopia: competing risk regression model. BMC Res Notes. 2018;11(1):1–6. doi:10.1186/s13104-018-3407-5
   PubMedGoogle Scholar
• Saumu WM, Maleche-Obimbo E, Irimu G, et al. Predictors of loss to follow-up among children attending HIV clinic in a hospital in rural Kenya. Pan Afr Med J. 2019;32(1). doi:10.11604/pamj.2019.32.216.18310
   PubMedGoogle Scholar
• Asiimwe SB, Kanyesigye M, Bwana B, et al. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa. BMC Infect Dis. 2015;16(1):1–10. doi:10.1186/s12879-016-1392-7
   Google Scholar
• Eguzo K, Lawal A, Umezurike C, et al. Predictors of loss to follow‑up among HIV‑infected patients in a rural South‑Eastern Nigeria Hospital: a 5‑year Retrospective Cohort Study. Ann Med Health Sci Res. 2015;5(6):373–378. doi:10.4103/2141-9248.177988
   PubMed Web of Science ®Google Scholar
• Nuwagira E, Lumori BAE, Muhindo R, et al. Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda. AIDS Res Ther. 2021;18(1):7. doi:10.1186/s12981-021-00331-5
   PubMed Web of Science ®Google Scholar
• Mutanga JN, Mutembo S, Ezeamama AE, et al. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015). BMC Public Health. 2019;19(1):1–13. doi:10.1186/s12889-019-7374-0
   PubMed Web of Science ®Google Scholar
• Gesesew HA, Ward P, Hajito KW, et al. Discontinuation from antiretroviral therapy: a continuing challenge among adults in HIV care in Ethiopia: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169651. doi:10.1371/journal.pone.0169651
   PubMed Web of Science ®Google Scholar
• Valenzuela C, Ugarte-Gil C, Paz J, et al. HIV stigma as a barrier to retention in HIV care at a general hospital in Lima, Peru: a case–control study. AIDS Behav. 2015;19:235–245. doi:10.1007/s10461-014-0908-7
   PubMed Web of Science ®Google Scholar
• Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155. doi:10.5001/omj.2011.38
   PubMedGoogle Scholar
• Praska JL, Kripalani S, Seright AL, et al. Identifying and assisting low-literacy patients with medication use: a survey of community pharmacies. Ann Pharmacother. 2005;39(9):1441–1445. doi:10.1345/aph.1G094
   PubMed Web of Science ®Google Scholar
• Barragán M, Hicks G, Williams MV, et al. Low health literacy is associated with HIV test acceptance. J Gen Intern Med. 2005;20(5):422–425. doi:10.1111/j.1525-1497.2005.40128.x
   PubMed Web of Science ®Google Scholar
• Nuwagira E, Amir A, Muzoora C. Predictors of Loss To FollOw up among HIV infected patients initiated on second line ART in Southwestern Uganda. HIV Curr Res. 2018;3(2):1–5.
   Google Scholar
• Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43(4):411. doi:10.1097/01.qai.0000243121.44659.a4
   PubMed Web of Science ®Google Scholar
• Doku D. Substance use and risky sexual behaviours among sexually experienced Ghanaian youth. BMC Public Health. 2012;12:1–7. doi:10.1186/1471-2458-12-571
   PubMed Web of Science ®Google Scholar
• Agbaji O, Abah I, Falang K, et al. Treatment discontinuation in adult HIV-infected patients on first-line antiretroviral therapy in Nigeria. Curr HIV Res. 2015;13(3):184–192. doi:10.2174/1570162X1303150506181945
   PubMed Web of Science ®Google Scholar
• Tran DA, Ngo AD, Shakeshaft A, et al. Trends in and determinants of loss to follow up and early mortality in a rapid expansion of the antiretroviral treatment program in Vietnam: findings from 13 outpatient clinics. PLoS One. 2013;8(9):e73181. doi:10.1371/journal.pone.0073181
   PubMed Web of Science ®Google Scholar
• Fonsah JY, Njamnshi AK, Kouanfack C, et al. Adherence to antiretroviral therapy (ART) in Yaoundé-Cameroon: association with opportunistic infections, depression, ART regimen and side effects. PLoS One. 2017;12(1):e0170893. doi:10.1371/journal.pone.0170893
   PubMed Web of Science ®Google Scholar